Immuneel Therapeutics - Total Funding, Funding Over Time, Funding By Rounds and More
Founded in 2018, Immuneel Therapeutics operates in Health Tech industry. Transitioning from research and development to clinical trials and commercialization, it secured funding in an extended Series ...
Funding stage:
Series B
Last funding:
07/06/2026
Total funding:
$37.13 Mn+
Revenue:
Investors
Employee count:
112
Last 90d
112
Last 90d
Web traffic:
2.32K
2.32K
Last 30d
Last 30d
Glassdoor Rating:
Immuneel Therapeutics: Funding Highlights
Funding highlights of Immuneel Therapeutics and a snapshot of its key metrics.
Total Funding$37.13 Mn+
Current StageGrowth Stage
Total Round(s)4
Funding Rounds
FAQs on Funding of Immuneel Therapeutics
Health Tech Funded Immuneel Therapeutics has raised a total funding of $37.13 million as of 08 June 2026 across 4 rounds. Find the details around funding rounds, participating investors, and other insights of Immuneel Therapeutics here...
Immuneel Therapeutics has raised a total of $37.13 million across 4 funding rounds and the last round was raised on 08 June 2026.
Immuneel Therapeutics's key investors include Eight Roads Ventures, F-Prime Capital, Kiran Mazumdar-Shaw and 2 others.
Immuneel Therapeutics's latest funding round was $10.00 million in Growth Stage, raised on 08 June 2026.
Immuneel Therapeutics is at the Growth stage. Its most recent round was raised on 08 June 2026.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links